Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Active vitamin D use was 80.6%, 99.1%, 98.4%, and 100.0%, respectively (P < 0.001).

Source: Clinical, biochemical, and treatment characteristics across predefined biochemical patterns. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Hyperphosphatemia-related biochemical profiles and clinical correlates in patients receiving maintenance hemodialysis: a single-center retrospective cross-sectional study

Source: Article title.

These patients were not retained in the analytical dataset.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Hyperphosphatemia-related biochemical profiles and clinical correlates in patients receiving maintenance hemodialysis: a single-center retrospective cross-sectional study

Cross-sectional study · Frontiers in Medicine · 2026

Original publication title

Hyperphosphatemia-related biochemical profiles and clinical correlates in patients receiving maintenance hemodialysis: a single-center retrospective cross-sectional study

Lei Zhang; Licun Zhang

© 2026 Zhang and Zhang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Predefined biochemical patterns captured heterogeneity in hyperphosphatemia among patients receiving MHD. Creatinine remained associated with hyperphosphatemia, uric acid showed a nonlinear but imprecise high-range association, and BUN was less consistent. These findings may help frame future studies of phosphate control using routinely available laboratory data.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Hyperphosphatemia is common in maintenance hemodialysis (MHD) and often coexists with other abnormalities of chronic kidney disease: mineral and bone disorder (CKD-MBD). We described predefined biochemical patterns related to hyperphosphatemia and examined their clinical correlates.

Source: Background

Abstract: What methods does the paper describe?

This single-center retrospective cross-sectional study screened 589 patients receiving hemodialysis between March 2023 to March 2026; 254 patients comprised the final complete-case analytical cohort. Four prespecified threshold-based biochemical patterns were defined using serum phosphorus, parathyroid hormone (PTH), and alkaline phosphatase (ALP). Univariable and fixed multivariable logistic regression were used to examine factors associated with hyperphosphatemia. Restricted cubic splines were used to assess the functional forms of BUN, uric acid, and creatinine. Sensitivity analyses and 1,000 bootstrap resamples were performed to examine the robustness of the adjusted estimates.

Source: Methods

Abstract: Results

Hyperphosphatemia was present in 182 patients (71.7%). The four patterns comprised 72 (28.3%) non-hyperphosphatemia, 106 (41.7%) HP/PTH−, 61 (24.0%) HP/PTH+/ALP−, and 15 (5.9%) HP/PTH+/ALP+. BUN, uric acid, and creatinine were higher in the hyperphosphatemic groups, whereas Kt/V was similar. After adjustment, creatinine was positively associated with hyperphosphatemia (OR 1.27 per 100 μmol/L, 95% CI 1.07 to 1.50, P = 0.005). Uric acid showed a nonlinear association (overall P = 0.005, P for nonlinearity=0.004), although estimates at the upper end of its distribution were less precise.

The BUN association was borderline (OR 1.33 per 5 mmol/L, 95% CI 1.00 to 1.78, P = 0.054) and weakened with the stricter phosphorus cutoff.

Source: Results

Abstract: Conclusion

Predefined biochemical patterns captured heterogeneity in hyperphosphatemia among patients receiving MHD. Creatinine remained associated with hyperphosphatemia, uric acid showed a nonlinear but imprecise high-range association, and BUN was less consistent. These findings may help frame future studies of phosphate control using routinely available laboratory data.

Source: Conclusion
Authors’ abstract

Background

Hyperphosphatemia is common in maintenance hemodialysis (MHD) and often coexists with other abnormalities of chronic kidney disease: mineral and bone disorder (CKD-MBD). We described predefined biochemical patterns related to hyperphosphatemia and examined their clinical correlates.

Methods

This single-center retrospective cross-sectional study screened 589 patients receiving hemodialysis between March 2023 to March 2026; 254 patients comprised the final complete-case analytical cohort. Four prespecified threshold-based biochemical patterns were defined using serum phosphorus, parathyroid hormone (PTH), and alkaline phosphatase (ALP). Univariable and fixed multivariable logistic regression were used to examine factors associated with hyperphosphatemia. Restricted cubic splines were used to assess the functional forms of BUN, uric acid, and creatinine. Sensitivity analyses and 1,000 bootstrap resamples were performed to examine the robustness of the adjusted estimates.

Results

Hyperphosphatemia was present in 182 patients (71.7%). The four patterns comprised 72 (28.3%) non-hyperphosphatemia, 106 (41.7%) HP/PTH−, 61 (24.0%) HP/PTH+/ALP−, and 15 (5.9%) HP/PTH+/ALP+. BUN, uric acid, and creatinine were higher in the hyperphosphatemic groups, whereas Kt/V was similar. After adjustment, creatinine was positively associated with hyperphosphatemia (OR 1.27 per 100 μmol/L, 95% CI 1.07 to 1.50, P = 0.005). Uric acid showed a nonlinear association (overall P = 0.005, P for nonlinearity=0.004), although estimates at the upper end of its distribution were less precise.

The BUN association was borderline (OR 1.33 per 5 mmol/L, 95% CI 1.00 to 1.78, P = 0.054) and weakened with the stricter phosphorus cutoff.

Conclusion

Predefined biochemical patterns captured heterogeneity in hyperphosphatemia among patients receiving MHD. Creatinine remained associated with hyperphosphatemia, uric acid showed a nonlinear but imprecise high-range association, and BUN was less consistent. These findings may help frame future studies of phosphate control using routinely available laboratory data.

Publication and source details

Original title: Hyperphosphatemia-related biochemical profiles and clinical correlates in patients receiving maintenance hemodialysis: a single-center retrospective cross-sectional study

Lei Zhang; Licun Zhang

Frontiers in Medicine · 2026

* Correspondence: Lei Zhang 16622875543@163.com© 2026 Zhang and Zhang.2026Zhang and Zhanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-13T04:18:35.010953+00:00

DOI: 10.3389/fmed.2026.1910971 · PMC13751438